| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (clinical) | 46 |
| Environment & ConservationLimit: Primarily for minority-owned businesses | 44 |
| Technology & SoftwareCurrently accepting applications | 39 |
| Education & TrainingLimit: Primarily for minority-owned businesses | 38 |
| Social Services & NonprofitLimit: Primarily for minority-owned businesses | 36 |
| Arts & CultureLimit: Primarily for minority-owned businesses | 35 |
| Industry | Estimated fit |
|---|---|
| Housing & Real EstateLimit: Primarily for minority-owned businesses | 35 |
| Energy & Clean TechLimit: Primarily for minority-owned businesses | 34 |
| Agriculture & FarmingLimit: Primarily for minority-owned businesses | 30 |
| Finance & BankingLimit: Primarily for minority-owned businesses | 30 |
| Food & BeverageLimit: Primarily for minority-owned businesses | 29 |
| ManufacturingLimit: Primarily for minority-owned businesses | 29 |
| Retail & E-CommerceLimit: Primarily for minority-owned businesses | 29 |
| Transportation & LogisticsLimit: Primarily for minority-owned businesses | 28 |
| Construction & InfrastructureLimit: Primarily for minority-owned businesses | 26 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH funds centers to join the IGVF Consortium, developing predictive computational models and integrative analyses of how genomic variation affects genome function. Eligible applicants include universities, nonprofits, state/local/tribal governments, and for-profit organizations including small businesses. About 5 awards; clinical trials not allowed.
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to develop, apply, and test predictive models and perform integrative analyses to determine the impact of genomic variation on genome function. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers also will collaborate with other consortium components to guide and optimize IGVF experimental design, to provide analytical expertise and support for consortium-wide efforts, and to develop and execute shared analysis strategies to meet consortium goals.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibilityForeign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…